Biotech IPO wave rolls on as Werewolf, Vaccitech raise $230M for clinical trials April 30, 2021 Auto Bot BioPharma, biopharma nl, Cambridge, cancer drugs, cancer immunotherapy, Clinical Trials, Massachusetts, Oxford, Pharma, United Kingdom 0 Vaccitech and Werewolf Therapeutics joined the public markets, raising a combined $230 million. The vaccine developer and the cancer immunotherapy biotech will apply the IPO proceeds toward clinical development of their respective pipelines.